Terms: = Germ cell tumor AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL
264 results:
1. Characteristics of pure tone audiogram in patients with untreated sporadic vestibular schwannoma: Analysis of audiometric shape and interaural differences stratified by age and mode of onset.
Tsuzuki N; Kitama T; Wasano K; Wakabayashi T; Hosoya M; Nishiyama T; Ozawa H; Oishi N
Auris Nasus Larynx; 2024 Apr; 51(2):347-355. PubMed ID: 37788966
[TBL] [Abstract] [Full Text] [Related]
2. Steroid Efficacy on Audiologic Recovery in Patients With Sudden Sensorineural Hearing Loss and Vestibular Schwannoma: A Retrospective Review.
Huynh PP; Saba ES; Hoerter JE; Jiang N
Otol Neurotol; 2023 Sep; 44(8):780-785. PubMed ID: 37464465
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.
Mariani P; Torossian N; van Laere S; Vermeulen P; de Koning L; Roman-Roman S; Lantz O; Rodrigues M; Stern MH; Gardrat S; Lesage L; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Romano E; Piperno-Neumann S; Lugassy C; Barnhill R
Br J Cancer; 2023 Sep; 129(5):772-781. PubMed ID: 37443346
[TBL] [Abstract] [Full Text] [Related]
4. Presbycusis and Hearing Preservation in Observed Vestibular Schwannomas.
Brennan JR; Sharma R; Lindquist NR; Cass ND; Krishnapura SG; Kloosterman N; Perkins E; Bennett ML; O'Malley MR; Haynes DS; Tawfik KO
Otol Neurotol; 2023 Sep; 44(8):817-821. PubMed ID: 37442597
[TBL] [Abstract] [Full Text] [Related]
5. Histopathological growth patterns of neuroendocrine tumor liver metastases.
Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
[TBL] [Abstract] [Full Text] [Related]
6. Defining triple-negative breast cancer with neuroendocrine differentiation (TNBC-NED).
Hacking SM; Yakirevich E; Wang Y
J Pathol Clin Res; 2023 Jul; 9(4):313-321. PubMed ID: 37082801
[TBL] [Abstract] [Full Text] [Related]
7. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
Geng T; Leung E; Chamley LW; Wu Z
Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
[TBL] [Abstract] [Full Text] [Related]
8. Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China.
Wang DY; Li SF; Gao SL; Yuan P; Zhang BL
Cancer Med; 2023 Apr; 12(8):9644-9649. PubMed ID: 36952359
[TBL] [Abstract] [Full Text] [Related]
9. Comparative outcomes of short-term and long-term fractionation with temozolomide in older glioblastoma patients: Single-center experience.
Uysal B; Gamsiz H; Sager O; Dincoglan F; Demiral S; Ozcan F; Colak O; Beyzadeoglu M
J Cancer Res Ther; 2022; 18(6):1610-1615. PubMed ID: 36412419
[TBL] [Abstract] [Full Text] [Related]
10. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].
Pan XY; Wu JK; Lang ZQ; Qu L; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):838-842. PubMed ID: 36097899
[No Abstract] [Full Text] [Related]
11. Prenatal ambient pesticide exposure and childhood retinoblastoma.
Thompson S; Ritz B; Cockburn M; Heck JE
Int J Hyg Environ Health; 2022 Aug; 245():114025. PubMed ID: 36037576
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review.
Bancheno WM; Adidam SR; Melaku MA
Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784
[TBL] [Abstract] [Full Text] [Related]
13. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
14. Primary Breast Neuroendocrine tumors: An Analysis of the National Cancer Database.
Martinez EO; Jorns JM; Kong AL; Kijak J; Lee WY; Huang CC; Cortina CS
Ann Surg Oncol; 2022 Oct; 29(10):6339-6346. PubMed ID: 35789311
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast.
Bean GR; Najjar S; Shin SJ; Hosfield EM; Caswell-Jin JL; Urisman A; Jones KD; Chen YY; Krings G
Mod Pathol; 2022 Oct; 35(10):1349-1361. PubMed ID: 35590107
[TBL] [Abstract] [Full Text] [Related]
16. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract] [Full Text] [Related]
17. A Novel
Zhang L; Du J; Song Q; Zhang C; Wu X
J Immunol Res; 2022; 2022():1178874. PubMed ID: 35155685
[TBL] [Abstract] [Full Text] [Related]
18. Aberrant nuclear lamina contributes to the malignancy of human gliomas.
Pei S; Wang X; Wang X; Huang H; Tao H; Xie B; Yang A; Qiu M; Tan Z
J Genet Genomics; 2022 Feb; 49(2):132-144. PubMed ID: 34530169
[TBL] [Abstract] [Full Text] [Related]
19. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Bourhis A; Caumont C; Quintin-Roué I; Magro E; Dissaux G; Remoué A; Le Noac'h P; Douet-Guilbert N; Seizeur R; Tyulyandina A; Schick U; Merlio JP; Marcorelles P; Cappellen D; Uguen A
Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
[TBL] [Abstract] [Full Text] [Related]
20. Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases.
Ikeda J; Ohe C; Ohsugi H; Matsuda T; Tsuta K; Kinoshita H
Pathol Int; 2021 Sep; 71(9):621-626. PubMed ID: 34297443
[TBL] [Abstract] [Full Text] [Related]
[Next]
